Joshua Miller - Concepedia

Author

Joshua Miller

University of Miami

Also Known As

D Mintz, J Miller, JOSHUA MILLER, Joshua Miller, Miller Joshua, Miller, Joshua, Miller,Joshua

177

Publications

5.9K

Citations

H-Index

114

Concepts

All Affiliations

University of Miami Northwestern University Miami Transplant Institute Miami VA Healthcare System Jesse Brown VA Medical Center

About

Joshua Miller is an author at University of Miami specializing in medicine, immunology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	33	1.4K
2	Allergy	2	2	52
3	Arts	1	1	29
4	Health Sciences	1	1	23
5	Language Studies	1	1	12

Joshua Miller

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation Joseph R. Leventhal, Michaël Abécassis, Joshua Miller, Science Translational Medicine	2012	465
A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years1 Flavio Vincenti, Stephen C. Jensik, Ronald S. Filo, Transplantation	2002	374
Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings Keith Zucker, Anne Rosén, Alexandra Tsaroucha, Transplant Immunology	1997	229
A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1 Gaetano Ciancio, George W. Burke, Jeffrey J. Gaynor, Transplantation	2005	217
The impact of hepatitis C virus infection on renal allograft recipients David Roth, Keith Zucker, Robert Cirocco, Kidney International TransplantationKidney TransplantHepatitis CViral HepatitisKidney Transplantation	1994	182
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. Ii. Survival, function, and protocol compliance at 1 year Gaetano Ciancio, George W. Burke, Jeffrey J. Gaynor, Transplantation	2004	160
Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Donor Stem Cell Infusion Joseph R. Leventhal, Michaël Abécassis, Joshua Miller, Transplantation	2012	151
HIGH-DOSE DONOR BONE MARROW INFUSIONS TO ENHANCE ALLOGRAFT SURVIVAL Camillo Ricordi, Theodore Karatzas, Jose Nery, Transplantation	1997	135
A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year Gaetano Ciancio, George W. Burke, Jeffrey J. Gaynor, Transplantation	2004	126
SIX-YEAR CLINICAL EFFECT OF DONOR BONE MARROW INFUSIONS IN RENAL TRANSPLANT PATIENTS1 Gaetano Ciancio, Joshua Miller, Rolando García-Morales, Transplantation	2001	125

Page 1